Undifferentiated small round cell sarcoma (USRCS) is a type of cancer affecting the bones and soft tissue. This rare form of cancer can affect people of all ages. USRCS is an extremely rare sarcoma ...
Dendritic cell sarcomas, encompassing a spectrum of neoplasms derived from accessory immune system cells, represent a rare and diagnostically challenging entity. Among these, follicular dendritic cell ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleucel (Tecelra ®, also known as afami-cel) for the treatment of adults with a rare ...
Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in an FDA nod in synovial sarcoma, a regulatory ...
Researchers at the Hollings Cancer Center at the Medical University of South Carolina find that polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
Clear cell sarcoma is an uncommon and aggressive soft tissue tumour that most often arises in the tendons and aponeuroses of young adults. It is distinguished by its melanocytic features and, in many ...
Chimeric antigen receptor (CAR)-T cells and T-cell therapies have been used in the treatment of various cancers for several years. In a review published in JAMA, a research team led by Christian ...
The immune system provides constant surveillance for the body, aiming to spot and eliminate disease-causing microbes or ...
The US Food and Drug Administration has approved afamitresgene autoleucel (afami-cel) (Tecelra, Adaptimmune LLC) to treat advanced synovial sarcoma. Afami-cel — the first engineered cell therapy for a ...
Please provide your email address to receive an email when new articles are posted on . Half of the patients in the phase 1 trial had either a complete response or stable disease. The trial’s next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback